MARKET

ANEB

ANEB

Anebulo Pharmaceuticals Inc
NASDAQ
0.5005
-0.3207
-39.05%
After Hours: 0.5100 +0.0095 +1.90% 18:48 02/06 EST
OPEN
0.4401
PREV CLOSE
0.8212
HIGH
0.6600
LOW
0.4351
VOLUME
793.19K
TURNOVER
--
52 WEEK HIGH
3.420
52 WEEK LOW
0.4351
MARKET CAP
20.56M
P/E (TTM)
-2.1271
1D
5D
1M
3M
1Y
5Y
1D
Anebulo Pharmaceuticals Announces Voluntary Nasdaq Delisting Plan
TipRanks · 21h ago
Anebulo Pharmaceuticals to voluntarily delist from Nasdaq
TipRanks · 22h ago
Anebulo Pharmaceuticals Voluntarily Delisting Common Shares From Nasdaq, Effective Feb. 27
Benzinga · 22h ago
BRIEF-Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC
Reuters · 22h ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 5d ago
Weekly Report: what happened at ANEB last week (0126-0130)?
Weekly Report · 5d ago
Anebulo Pharmaceuticals Completes Oversubscribed Share Repurchase Tender
TipRanks · 01/29 15:03
Anebulo Pharmaceuticals Buys Back 300,000 Shares at $3.50 Each for $1.05 Million
Reuters · 01/29 14:01
More
About ANEB
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company. It is engaged in developing treatments for cannabis toxicity, such as unintentional cannabis poisoning, acute cannabinoid intoxication (ACI) and the landscape of acute cannabis-induced conditions. Its lead product candidate is selonabant, a potent, small molecule antagonist of cannabinoid binding receptor type-1 (CB1), the primary receptor involved in the psychotropic effects of cannabinoids, with the potential to address the unmet medical need for a therapy to treat cannabis toxicity. Selonabant is orally bioavailable, rapidly absorbed, and has also been formulated for intravenous administration. Selonabant is intended to rapidly reverse the negative effects of cannabis-induced toxicity and reduce time to recovery. It is also prioritizing the advancement of a selonabant intravenous (IV) formulation as a potential treatment for pediatric patients with cannabis-induced CNS depression.

Webull offers Anebulo Pharmaceuticals Inc stock information, including NASDAQ: ANEB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANEB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANEB stock methods without spending real money on the virtual paper trading platform.